Member access

4-Traders Homepage  >  Shares  >  Amex  >  IGI LABORIGI       

 SummaryChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Company
IGI Laboratories, Inc. develops, manufactures and markets topical formulations.The company sells generic topical pharmaceutical products under IGI label.It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.The company's... 
Sector
Pharmaceuticals
Calendar
03/17Earnings Release
More about the company
Surperformance© ratings of IGI LABORIGI
Trading Rating : Investor Rating : -
More Ratings
Chart IGI LABORIGI
Duration : Period :
IGI LABORIGI Technical Analysis Chart | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 31,9 M
EBIT 2014 2,80 M
Net income 2014 2,58 M
Debt 2014 -
Yield 2014 -
Sales 2015 60,4 M
EBIT 2015 15,3 M
Net income 2015 14,1 M
Debt 2015 -
Yield 2015 -
PER 2014 198,40
PER 2015 37,79
Capi. / Sales 2014 16,4x
Capi. / Sales 2015 8,67x
Capitalization 524 M
More Financials
Latest news on IGI LABORIGI
3d ago IGI LABORATORIES : Consumer Staples Industry Equities under the Scanner -- Proct..
4d ago IGI LABORATORIES : Announces Closing of $125 Million of 3.75% Convertible Senior..
12/11 IGI LABORATORIES : Announces Pricing of $125 Million of 3.75% Convertible Senior..
12/10 IGI LABORATORIES : To Present At 25TH Annual Oppenheimer Healthcare Conference O..
12/09 IGI LABORATORIES : Announces Proposed Offering of $125 Million of Convertible Se..
12/02 IGI LABORATORIES : To Present At Piper Jaffray 26th Annual Healthcare Conference..
12/01 IGI LABORATORIES : Announces 8th ANDA Submission Of 2014
11/24 IGI LABORATORIES : Announces ANDA Submission
More news
Sector news
5h ago Fear factor fades as global M&A hits seven-year high
1d ago AstraZeneca CEO says new Pfizer bid unlikely - Swedish daily DI
2d ago JAZZ PHARMACEUTICALS : Receives FDA Approval For Intravenous Administration Of E..
More sector news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF